#ESGCT
Very pleased to share - my highlights from the ESGCT Congress 2024 in Rome a couple of months ago are now online!

#genetherapy #celltherapy #biomedical #research #scientificpublishing @ebiomedicine.bsky.social
European Society of Gene and Cell Therapy Congress, 22–25 October 2024
The 31st annual ESGCT Congress was held at the end of October inside the impressive ‘La Nuvola’ (‘the cloud’) convention centre in Rome. This year's event was the largest ever, with 2700 participants ...
www.thelancet.com
January 14, 2025 at 5:32 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVcPqP #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
September 23, 2026 at 3:00 PM
Thrilled to be nominated in the Working Group on ‘Disease Models/iPS Cells/Organoids’ of the European Society of Gene and Cell Therapy (ESGCT).
www.esgct.eu
December 5, 2024 at 7:48 PM
Our team is on their way to the ESGCT conference 2025! Excited for this upcoming week full of science, talks, and inspiring discussions with the cell & gene therapy community!
Starting with the HDR workshop - talks by Isabell (‘one-pot’ PASTA) & Viktor
(BEKI) + posters by Ana, Lily, Jonas and Laura
October 5, 2025 at 8:51 PM
Planning to attend the ESGCT meeting this fall? If you'll already be in Seville, Spain Oct. 6, join us for the 14th Stem Cell Clonality and Genome Stability Retreat!

Speakers will update attendees on the progress in #geneediting, in vivo gene delivery, and more. lnkd.in/gYbTq49c
June 4, 2025 at 7:53 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TLmD5k #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
July 6, 2025 at 2:59 PM
Thank you for a wonderful #ThemeDay25 in Dresden
and see you at the DGGT/ESGCT Springschool in Postdam,
the 32. ESGCT Congress this fall in Sevilla,
or next year at the joint #DGGTeV and 33. #ESGCT Congress 2026 in Hamburg

https://www.esgct.eu/upcoming-events
March 11, 2025 at 2:00 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TPnWL3 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
December 12, 2025 at 7:06 PM
SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, Ultrasound-Mediated Delivery to Treat Duchenne Muscular Dystrophy - www.businesswire.com/news/home/20...
October 7, 2025 at 11:53 AM
#ESGCT2025: A woman who was previously ineligible for @genethonfr.bsky.social's Crigler–Najjar syndrome gene therapy due to pre-existing immunity to AAV8 got the treatment after Hansa Bio's antibody-chopping drug imlifidase cleared the way. Read more in @endpts.com :

endpoints.news/new-study-su...
Person previously ineligible for gene therapy granted treatment after antibody-chopping drug clears the way
Study shows Hansa's Idefirix helps deliver Genethon's AAV8 gene therapy GNT003 in previously ineligible Crigler-Najjar patient by clearing antibodies, reports Do Cao at ESGCT.
endpoints.news
October 10, 2025 at 7:16 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TS6NpG #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
April 19, 2026 at 9:23 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TP6707 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
November 6, 2025 at 10:19 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVL5wC #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
September 5, 2026 at 8:00 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TQxgFL #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
February 13, 2026 at 7:09 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TLv6z5 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
July 13, 2025 at 6:07 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TV3FBy #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
August 17, 2026 at 3:00 PM
Our PhD student Diogo Fernandes is presenting our latest work on the development of a gene therapy for Lama2-md at the ESGCT 2025 congress. If you are interested look for poster P048!
October 7, 2025 at 3:13 PM
🧠IXICO at upcoming scientific congresses 🧠
➡️Niccolo Fuin & Vahid Malekian are attending #ESMRMB in Marseille, 8–11 Oct
➡️Kirsi Kinnunen will be at #ESGCT in Seville, 7–10 Oct,

🧠 Connect with us at both events: ixico.com/contact-us
September 24, 2025 at 8:57 PM
We’re not just exhibiting—we’re collaborating.
Find us at A21 tomorrow (10/7) and let’s align on goals, constraints, and a realistic path to data.

📍 FIBES | Oct 7–10
#AAV #Adenovirus #GeneTherapy #AdvancedTherapies #ESGCT.
October 6, 2025 at 4:02 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TNr4Z0 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
October 23, 2025 at 9:22 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TNjFpJ #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
October 16, 2025 at 7:59 AM
We are proud to see young German researchers presenting their exciting work at ESGCT:

🎤 Presentations:
Akshatha Shivaraj
Kerstin Geiger

🖼️ Posters:
Stylianos Michalakis
Fabian John
Muhammed Burak Demircan
Maren Soldierer
Alexandre Trubert
Melissa Whitehead

#DGGTeV #GeneTherapy #ESGCT2025
October 6, 2025 at 2:00 PM
[ESGCT CONGRES]
🎉 Du 7 au 10 octobre, @genethonfr.bsky.social sera à l'honneur lors du congrès #ESGCT2025 à Séville !
🔬 4 présentations orales, 19 posters – 2 sessions co-présidées.
🌍 Rencontrons-nous!
👉Actualité : urlr.me/aWVrAE
#Genethon #DMD #MaladiesRares #Recherche
October 1, 2025 at 2:05 PM
We’re excited to attend ESGCT, the premier event for gene and cell therapy innovation in Europe!

Join us at booth A23 to explore our innovative CRISPR technologies and GMP solutions designed to help you rapidly move from the lab to life-changing advances. Learn more: https://www.esgctcongress.com/
September 24, 2025 at 6:30 AM